HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-(2-Piperazin-1-ylethyl)-2,1,3-benzoxadiazole → 5-[(1R)-2-{4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl}-1-hydroxyethyl]-4-methyl-2-benzofuran-1(3H)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-(2-Piperazin-1-ylethyl)-2,1,3-benzoxadiazole | HCID 15166382 | — |
| Reactant | 4-Methyl-5-((2R)-oxiran-2-yl)-2-benzofuran-1(3H)-one | HCID 59568646 | — |
| Product | 5-[(1R)-2-{4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl}-1-hydroxyethyl]-4-methyl-2-benzofuran-1(3H)-one | HCID 59568663 | — |
Reaction Steps
5-[(1R)-2-{4-[2-(2,1,3-benzoxadiazol-5-yl)ethyl]piperazin-1-yl}-1-hydroxyethyl]-4-methyl-2-benzofuran-1 (3H)-one was prepared in a similar fashion as to the synthesis described in EXAMPLE 12 starting from 5-[2-(piperazin-1-yl)ethyl]-2,1,3-benzoxadiazole and 4-methyl-5-[(2R)-oxiran-2-yl]-2-benzofuran-1(3H)-one. LC/MS: [(M+1)]+=423.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09018211B2 |
| Source dataset | uspto-grants-2015_04 |
| ORD ID | ord-b8c3e3db4b62404bb19c7440ae16697d |
| Source note | uspto-grants-2015_04 |